Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA as effective as sumatriptan in treatment of acute migraines
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Pain Managers and Prescribers
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol Full Text JACC - Journal of the American College of Cardiology, October 8, 2012 Original Publication Date: October 7, 2011 Clinical Article
2 New data from ORIGIN Shows Lantus use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population Full Text Sanofi-aventis, October 8, 2012
3 The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain Full Text Molecular Pain, October 8, 2012
4 A Phase I Dose Esclation Study of Tivantinib in Adult Pts w Metastatic Solid Tumors Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011 Clinical Article
5 Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar Full Text PLoS Neglected Tropical Diseases, October 8, 2012 Clinical Article
6 Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, 3, in Patients with Metastatic Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011 Clinical Article
7 Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258)-an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors-in Patients with Advanced Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011 Clinical Article
8 A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors Full Text Investigational New Drugs, October 8, 2012 Clinical Article
9 Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors Full Text Investigational New Drugs, October 8, 2012 Clinical Article
10 GPhA Receives Favorable Opinion on Shortage Initiative Full Text U.S. Pharmacist, October 8, 2012
11 Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Full Text JACC - Journal of the American College of Cardiology, October 7, 2012 Original Publication Date: October 6, 2011 Clinical Article
12 Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 6, 2011 Clinical Article
13 Impact of the Everolimus-Eluting Stent on Stent Thrombosis: A Meta-Analysis of 13 Randomized Trials Full Text JACC - Journal of the American College of Cardiology, October 7, 2012 Original Publication Date: October 7, 2011 Evidence Based Medicine Clinical Article
14 Randomized front line trial utilizing tumor genomic profiling tests OPAXIO plus radiation therapy compared to current standard of care of radiation with temozolamide in high risk patients with glioblastoma multiforme Full Text Cell Therapeutics, October 5, 2012
15 In vitro Characterization of the Oxidation of a Pyridinium Metabolite of Haloperidol by Human Placenta: The Effect of Smoking Full Text Journal of Pharmacy and Pharmaceutical Sciences, October 5, 2012
16 Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy Full Text BMC Neurology, October 5, 2012
17 Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection Full Text Biologics: targets & therapy, October 5, 2012 Clinical Article
18 Dopamine Receptor Blockade Attenuates the General Incentive Motivational Effects of Noncontingently Delivered Rewards and Reward-Paired Cues Without Affecting Their Ability to Bias Action Selection Full Text Neuropsychopharmacology, October 5, 2012 Original Publication Date: October 4, 2011
19 Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV Full Text GlaxoSmithKline, October 5, 2012
20 Distinct Contributions of Dopamine in the Dorsolateral Striatum and Nucleus Accumbens Shell to the Reinforcing Properties of Cocaine Full Text Neuropsychopharmacology, October 5, 2012 Original Publication Date: October 4, 2011
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close